Home
About Us
Background
Investment Strategy
Team
Portfolio
News
Contact
中文
Investor Login
Home
About Us
Background
Investment Strategy
Team
Portfolio
News
Contact
中文
Investor Login
We are Company Builders
Identifying, incubating and growing future industry leaders in life sciences.
We are Industry Veterans
Capturing evolving healthcare trends and emerging cutting-edge innovations
We are Preferred Partners
Connecting companies with extensive network and resources globally and in China
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
...
November 26, 2025
Avenzo Therapeutics Announces Appointment of Scott Lipman as Chief Financial Officer
...
November 19, 2025
NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts
...
November 17, 2025
All news